Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: An association study in a South American population isolate

Human Heredity

Volumn 67, Issue 3, 2009, Pages 163-173

  Kremeyer, Barbara ^a   García, Jenny ^b   Kymäläinen, Hanna ^a   Wratten, Naomi ^c   Restrepo, Gabriel ^b   Palacio, Carlos ^b   Miranda, Ana Lucía ^b   López, Carlos ^b   Restrepo, Margarita ^b   Bedoya, Gabriel ^b   Brzustowicz, Linda M ^c,d   Ospina Duque, Jorge ^b   Arbeláez, María Patricia ^b   Ruiz Linares, Andrés ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c Rutgers University   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Clinical heterogeneity; Genetic association; NOS1AP; Psychiatric genetics; Schizophrenia

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CHROMOSOME 1Q; CLINICAL FEATURE; DISEASE PREDISPOSITION; FACTORIAL ANALYSIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; NEURONAL NITRIC OXIDE SYNTHASE 1 ADAPTOR PROTEIN GENE; REPLICATION STUDY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AMERICA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BASE SEQUENCE; FACTOR ANALYSIS, STATISTICAL; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA; SOUTH AMERICA; YOUNG ADULT;

EID: 57449100523     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000181154     Document Type: Article

References (46)

1. Saha S, Chant D, Welham J, McGrath J: A systematic review of the prevalence of schizophrenia. PLOS Medicine 2005;2:413-433.
2. Craddock N, O'Donovan MC, Owen MJ: The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005;42:193-204.
3. Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, O'Neill FA, Walsh D, Kendler KS: Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 2002;7:542-559.
4. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis S, Pulver AE: Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998;20:70-73.
5. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS: Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000;288:678-682.
6. Brzustowicz LM, Honer WG, Chow EW, Little D, Hogan J, Hodgkinson K, Bassett AS: Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 1999;65:1096-1103.
7. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, Markey CJ, Beshah E, Guroff JJ, Maxwell ME, Kazuba DM, Whiten R, Goldin LR, Gershon ES, Gejman PV: Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997;43:1-8.
8. Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, Sherrington R, Adolfsson R, Jazin E: A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet 2001;69:96-105.
9. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, et al: Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003;73:34-48.
10. Coyle JT: Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006;26:365-384.
11. Brzustowicz LM, Simone J, Mohseni P, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS: Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet 2004;74:1057-1063.
12. Zheng Y, Li H, Qin W, Chen W, Duan Y, Xiao Y, Li C, Zhang J, Li X, Feng G, He L: Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population. Biochem Biophys Res Commun 2005;328:809-815.
13. Bedoya G, Montoya P, Garcia J, Soto I, Bourgeois S, Carvajal L, Labuda D, Alvarez V, Ospina J, Hedrick PW, Ruiz-Linares A: Admixture dynamics in Hispanics: A shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci USA 2006;103:7234-7239.
14. Carvajal-Carmona LG, Ophoff R, Service S, Hartiala J, Molina J, Leon P, Ospina J, Bedoya G, Freimer N, Ruiz-Linares A: Genetic demography of Antioquia (Colombia) and the Central Valley of Costa Rica. Hum Genet 2003;112:534-541.
15. Carvajal-Carmona LG, Soto ID, Pineda N, Ortiz-Barrientos D, Duque C, Ospina-Duque J, McCarthy M, Montoya P, Alvarez VM, Bedoya G, Ruiz-Linares A: Strong Amerind/white sex bias and a possible Sephardic contribution among the founders of a population in northwest Colombia. Am J Hum Genet 2000;67:1287-1295.
16. Miranda A, Garcia J, Lopez C, Gordon D, Palacio C, Restrepo G, Ortiz J, Montoya G, Cardeno C, Calle J, Lopez M, Campo O, Bedoya G, Ruiz-Linares A, Ospina-Duque J: Putative association of the carboxy-terminal PDZ ligand of neuronal nitric oxide synthase gene (CAPON) with schizophrenia in a Colombian population. Schizophr Res 2006;82:283-285.
17. Puri V, McQuillin A, Thirumalai S, Lawrence J, Krasucki R, Choudhury K, Datta S, Kerwin S, Quested D, Bass N, Pimm J, Lamb G, Moorey H, Kandasami G, Badacsonyi A, Kelly K, Morgan J, Punukollu B, Nadeem H, Curtis D, Gurling HMD: Failure to confirm allelic association between markers at the CAPON gene locus and schizophrenia in a British sample. Biol Psychiatry 2006;59:195-197.
18. Tamminga CA, Holcomb HH: Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 2005;10:27-39.
19. Fanous AH, Kendler KS: Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 2005;10:6-13.
20. Peralta V, Cuesta MJ: How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001;49:269-285.
21. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994;51:849-859.
22. Palacio CA, García J, Arbeláez MP, Sánchez R, Aguirre B, Garcés I, Montoya GJ, Gómez J, Agudelo A, López CA, Calle JJ, Cardeño CA, Cano JF, López MC, Montoya P, Herrera CP, González N, González A, Bedoya G, Ruiz A, Ospina J: Validación de la entrevista diagnóstica para estudios genéticos (DIGS) en Colombia. Biomédica 2004;24:56-62.
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed. 4. Washington, DC, American Psychiatric Association, 2000.
24. Andreasen NC: The Scale for the assessment of positive symptoms (SAPS). Iowa City, The University of Iowa, 1984.
25. Andreasen NC: The Scale for the Assessment of Negative Symtoms (SANS): conceptual and theorical foundations. Br J Psychiatry Suppl 1989;7:49-58.
26. García J, Palacio CA, Garcés I, Arbeláez MP, Sánchez R, López CA, Montoya GJ, González N, González A, Ospina J: Inferencias fenomenológicas y nosoógicas en la esquizofrenia a partir de la validación de las escalas de síntomas positivos (SAPS) y de síntomas negativos (SANS) en Colombia. Revista de Neuro-Psiquiatría 2003;66:195-214.
27. Dawson B, Trapp RG, Trapp R: Statistical methods for multiple variables. Basic And Clinical Biostatistics, ed 4. Norwalk, Appleton & Lange, 2004, pp 245-279.
28. Kline P: The Handbook of Psychological Testing. London, Routledge, 1993.
29. Wratten N, Bruse SE, Azaro MA, Simone J, Hayter JE, Brzustowicz LM: Identifying schizophrenia-associated non-coding variants in the CAPON gene (abstract). 55th Annual Meeting of the American Society of Human Genetics, Salt Lake City, Utah 2005, Oct 25-29.
30. Wang HY, Luo M, Tereshchenko IV, Frikker DM, Cui X, Li JY, Hu G, Chu Y, Azaro MA, Lin Y, Shen L, Yang Q, Kambouris ME, Gao R, Shih W, Li H: A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome. Genome Res 2005;15:276-283.
31. Taylor JD, Briley D, Nguyen Q, Long K, Iannone MA, Li MS, Ye F, Afshari A, Lai E, Wagner M, Chen J, Weiner MP: Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 2001;30:661-669.
32. Bruse SE, McGregor N, Azaro MA, Xu B, Brzustowicz LM: An inexpensive bead-based oligonucleotide ligation assay for SNP genotyping (abstract). 56th Meeting of the American Society of Human Genetics, New Orleans, La. 2006, Oct 9-13.
33. Raymond M, Rousset F: GENEPOP (Version 1.2): population genetics software for exact tests and ecumenicism. J Hered 1995;86:248-249.
34. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-121.
35. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-516.
36. Clayton D: A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999;65:1170-1177.
37. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
38. Purcell S, Daly MJ, Sham PC: WHAP: haplotype-based association analysis. Bioinformatics 2007;23:255-256.
39. Kaiser HF: Index of Factorial Simplicity. Psychometrika 1974;39:31-36.
40. Cattell RB: The scree test for the number of factors. Multivar Behav Res 1966;1:245-276.
41. Abecasis GR, Cardon LR, Cookson WO: A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000;66:279-292.
42. Coyle JT, Tsai G, Goff D: Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 2003 Nov;1003:318-327.
43. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH: CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 1998;20:115-124.
44. Xu B, Wratten N, Charych EI, Buyske S, Firestein BL, Brzustowicz LM: Increased Expression in Dorsolateral Prefrontal Cortex of CAPON in Schizophrenia and Bipolar Disorder. PLoS Med 2005;2:e263.
45. Pagani F, Raponi M, Baralle FE: Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci USA 2005;102:6368-6372.
46. Puri V, McQuillin A, Choudhury K, Datta S, Pimm J, Thirumalai S, Krasucki R, Lawrence J, Quested D, Bass N, Moorey H, Morgan J, Punukollu B, Kandasami G, Curtis D, Gurling H: Fine Mapping by Genetic Association Implicates the Chromosome 1q23.3 Gene UHMK1, Encoding a Serine/Threonine Protein Kinase, as a Novel Schizophrenia Susceptibility Gene. Biol Psychiatry 2006;61:873-879.